Endovascular Treatment for Acute Portal Vein Thrombosis.

Tatsuo Ueda, Hidemasa Saito, Sayaka Shirai, Fumie Sugihara, Ryutaro Fujitsuna, Taiga Matsumoto, Hiromitsu Hayashi, Shin-Ichiro Kumita
{"title":"Endovascular Treatment for Acute Portal Vein Thrombosis.","authors":"Tatsuo Ueda, Hidemasa Saito, Sayaka Shirai, Fumie Sugihara, Ryutaro Fujitsuna, Taiga Matsumoto, Hiromitsu Hayashi, Shin-Ichiro Kumita","doi":"10.22575/interventionalradiology.2023-0027","DOIUrl":null,"url":null,"abstract":"<p><p>Acute portal vein thrombosis is characterized by nonspecific abdominal pain, causing severe morbidity and mortality. Prompt diagnosis is crucial to avoid short-term complications such as intestinal infarction, sepsis, and death. The therapeutic goal is to prevent thrombus extension into the mesenteric veins and intestinal ischemia complications. Systemic anticoagulation is the standard treatment. However, endovascular treatments such as thrombolysis, thrombectomy, balloon angioplasty, stent placement, and transjugular intrahepatic portosystemic shunt placement have been performed in patients who are refractory to anticoagulation therapy or at a high risk of intestinal ischemia. This review discusses the clinical and diagnostic considerations in acute portal vein thrombosis, focusing on current endovascular treatments that are effective and safe. However, prospective data are required to compare endovascular treatment techniques and assess their outcomes.</p>","PeriodicalId":73503,"journal":{"name":"Interventional radiology (Higashimatsuyama-shi (Japan)","volume":"10 ","pages":"e20230027"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12078051/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional radiology (Higashimatsuyama-shi (Japan)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22575/interventionalradiology.2023-0027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/28 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Acute portal vein thrombosis is characterized by nonspecific abdominal pain, causing severe morbidity and mortality. Prompt diagnosis is crucial to avoid short-term complications such as intestinal infarction, sepsis, and death. The therapeutic goal is to prevent thrombus extension into the mesenteric veins and intestinal ischemia complications. Systemic anticoagulation is the standard treatment. However, endovascular treatments such as thrombolysis, thrombectomy, balloon angioplasty, stent placement, and transjugular intrahepatic portosystemic shunt placement have been performed in patients who are refractory to anticoagulation therapy or at a high risk of intestinal ischemia. This review discusses the clinical and diagnostic considerations in acute portal vein thrombosis, focusing on current endovascular treatments that are effective and safe. However, prospective data are required to compare endovascular treatment techniques and assess their outcomes.

急性门静脉血栓的血管内治疗。
急性门静脉血栓形成以非特异性腹痛为特征,可引起严重的发病率和死亡率。及时诊断对于避免肠梗死、败血症和死亡等短期并发症至关重要。治疗目的是防止血栓扩展到肠系膜静脉和肠缺血并发症。全身抗凝是标准的治疗方法。然而,血管内治疗如溶栓、取栓、球囊血管成形术、支架置入术和经颈静脉肝内门静脉系统分流置入术已被用于抗凝治疗难治性或肠缺血高风险的患者。本文综述了急性门静脉血栓形成的临床和诊断注意事项,重点介绍了目前有效和安全的血管内治疗方法。然而,需要前瞻性数据来比较血管内治疗技术并评估其结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信